International audienceBackground: Knowing who will develop Alzheimer's disease (AD) and when is a crucial health issue, that could help treat subjects earlier, using new treatments targeting the earliest stages. We have participated in TADPOLE, a competition based on ADNI data aiming at developing an automatic prognosis system. We propose a method for predicting the time to conversion of MCI subjects to AD and a framework to evaluate such predictions. Method: We decompose the prediction into two steps: first, we monthly predict future values of the cognitive scores of each subject; second, we use them to automatically predict the corresponding disease status, using a Support Vector Machine. For the first step, we compare two approaches: the...
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders among the elderly pop...
© 2019, The Author(s). Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked ...
In the Alzheimer's disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) pr...
International audienceBackground: Knowing who will develop Alzheimer's disease (AD) and when is a cr...
Alzheimer’s disease (AD), the most common form of dementia, is a slowly progressing neurodegenerativ...
Background: Available therapies for Alzheimer's disease (AD) can only alleviate and delay the advanc...
Alzheimer’s disease is a degenerative brain disease which impairs a person’s ability to perform day ...
Mild cognitive impairment is a preclinical stage of Alzheimer's disease (AD). For effective treatmen...
Treball de fi de grau en BiomèdicaTutors: Oscar Camara Rey, Gerard Sanroma GüellAlzheimer’s Disease ...
Background: Despite the increasing availability in brain health related data, clinically translatabl...
Progression to dementia due to Alzheimer’s Disease (AD) is a long and protracted process that involv...
In Alzheimer’s disease (AD) progression, it is imperative to identify the subjects with mild cogniti...
International audienceThe anticipation of progression of Alzheimer’s disease (AD) is crucial for eva...
INTRODUCTION: Developing cross-validated multi-biomarker models for the prediction of the rate of co...
Background: The course of Alzheimer’s disease (AD) is heterogenous, in part because of individual he...
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders among the elderly pop...
© 2019, The Author(s). Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked ...
In the Alzheimer's disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) pr...
International audienceBackground: Knowing who will develop Alzheimer's disease (AD) and when is a cr...
Alzheimer’s disease (AD), the most common form of dementia, is a slowly progressing neurodegenerativ...
Background: Available therapies for Alzheimer's disease (AD) can only alleviate and delay the advanc...
Alzheimer’s disease is a degenerative brain disease which impairs a person’s ability to perform day ...
Mild cognitive impairment is a preclinical stage of Alzheimer's disease (AD). For effective treatmen...
Treball de fi de grau en BiomèdicaTutors: Oscar Camara Rey, Gerard Sanroma GüellAlzheimer’s Disease ...
Background: Despite the increasing availability in brain health related data, clinically translatabl...
Progression to dementia due to Alzheimer’s Disease (AD) is a long and protracted process that involv...
In Alzheimer’s disease (AD) progression, it is imperative to identify the subjects with mild cogniti...
International audienceThe anticipation of progression of Alzheimer’s disease (AD) is crucial for eva...
INTRODUCTION: Developing cross-validated multi-biomarker models for the prediction of the rate of co...
Background: The course of Alzheimer’s disease (AD) is heterogenous, in part because of individual he...
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders among the elderly pop...
© 2019, The Author(s). Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked ...
In the Alzheimer's disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) pr...